Insulin versus a combination of insulin and sulfonylurea in the treatment of NIDDM patients with secondary oral failure.

@article{RavnikOblak1995InsulinVA,
  title={Insulin versus a combination of insulin and sulfonylurea in the treatment of NIDDM patients with secondary oral failure.},
  author={Maja Ravnik-Oblak and F Mrevlje},
  journal={Diabetes research and clinical practice},
  year={1995},
  volume={30 1},
  pages={27-35}
}
AIM Comparison of the effectiveness of combined therapy vs. an insulin regimen in NIDDM patients with secondary failure of oral hypoglycemic agents. RESEARCH DESIGN, PATIENTS AND METHODS: 27 NIDDM patients were randomly allocated to Group A (n = 14, insulin) and Group B (n = 13, insulin and sulfonylurea) with crossover after 3 months. After the next 3 months a decision was made about the further treatment according to the metabolic control. The patients were then treated for another year with… CONTINUE READING